The connections among dysregulated Myc, proteasomal substrate proteins Ikaros (IKZF1) and Aiolos (IKZF3), and lenalidomide have been verified in multiple myeloma [7], but not yet in MDS. This evidence concerns the gene IKZF1 and plasma cell myeloma.